Literature DB >> 26823697

Mixed group of Rhizobiales microbes in lung and blood of a patient with fatal pulmonary illness.

Shyh-Ching Lo1, Guo-Chiuan Hung1, Bingjie Li1, Haiyan Lei1, Tianwei Li1, Kenjiro Nagamine1, Shien Tsai1, Mark J Zucker2, Ludmilla Olesnicky3.   

Abstract

We examined the microbial composition in the diseased lung and early-phase microbial cultures from the blood of a patient with a rapidly progressing fatal pulmonary illness. Although no microbes could be isolated from such cultures during the initial study, the HTS-microbiome study revealed the presence of a unique mixture of alphaproteobacteria, composed mainly of different families of Rhizobiales microbes. Microbial 16S rDNA sequences matching closely to Afipia cberi were identified mainly in the patient's diseased lung tissue, but only rarely in the early-phase blood cultures. Conversely, the high abundance of sequences found in early-phase blood cultures of different broth media matched closely with those of the families Methylobacteriaceae, Phyllobacteriaceae and Sphingomonadaceae. The two species that successfully adapted to grow in a laboratory culture system were A. cberi and Mesorhizobium hominis, which eventually were isolated from a previously cryopreserved blood culture of SP4 broth. Many other species, including members of the Bradyrhizobiaceae and Phyllobacteriaceae families, and all members of the Methylobacteriaceae and Sphingomonadaceae families identified by HTS remained non-cultivated. We developed specific PCR primers and FISH probes, which detected the target Rhizobiales microbes in former blood cultures and autopsy lung tissues. It is unclear what role these Rhizobiales microbes might have played in the patient's complex disease process. However, the above mentioned assays should help in rapidly detecting and identifying these previously unrecognized Rhizobiales microbes in patients.

Entities:  

Keywords:  Afipia; Bradyrhizobiaceae; HTS; MPS; Mesorhizobium; Methylobacteriaceae; Microbiome; Phyllobacteriaceae; Rhizobiales; Sphingomonadaceae; alphaproteobacteria

Mesh:

Substances:

Year:  2015        PMID: 26823697      PMCID: PMC4713483     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  EMBOSS: the European Molecular Biology Open Software Suite.

Authors:  P Rice; I Longden; A Bleasby
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

2.  Integrative analysis of environmental sequences using MEGAN4.

Authors:  Daniel H Huson; Suparna Mitra; Hans-Joachim Ruscheweyh; Nico Weber; Stephan C Schuster
Journal:  Genome Res       Date:  2011-06-20       Impact factor: 9.043

3.  The lung microbiome. A new frontier in pulmonary medicine.

Authors:  James P Kiley; Elisabet V Caler
Journal:  Ann Am Thorac Soc       Date:  2014-01

4.  Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project.

Authors:  Leslie G Biesecker
Journal:  Genet Med       Date:  2012-02-16       Impact factor: 8.822

5.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

6.  Isolation of novel Afipia septicemium and identification of previously unknown bacteria Bradyrhizobium sp. OHSU_III from blood of patients with poorly defined illnesses.

Authors:  Shyh-Ching Lo; Guo-Chiuan Hung; Bingjie Li; Haiyan Lei; Tianwei Li; Kenjiro Nagamine; Jing Zhang; Shien Tsai; Richard Bryant
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

7.  Reagent and laboratory contamination can critically impact sequence-based microbiome analyses.

Authors:  Susannah J Salter; Michael J Cox; Elena M Turek; Szymon T Calus; William O Cookson; Miriam F Moffatt; Paul Turner; Julian Parkhill; Nicholas J Loman; Alan W Walker
Journal:  BMC Biol       Date:  2014-11-12       Impact factor: 7.431

8.  Chapter 12: Human microbiome analysis.

Authors:  Xochitl C Morgan; Curtis Huttenhower
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

9.  Isolation and characterization of two novel bacteria Afipia cberi and Mesorhizobium hominis from blood of a patient afflicted with fatal pulmonary illness.

Authors:  Shyh-Ching Lo; Bingjie Li; Guo-Chiuan Hung; Haiyan Lei; Tianwei Li; Jing Zhang; Kenjiro Nagamine; Shien Tsai; Mark J Zucker; Ludmilla Olesnicky
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

Review 10.  Polybacterial human disease: the ills of social networking.

Authors:  Francesca L Short; Sarah L Murdoch; Robert P Ryan
Journal:  Trends Microbiol       Date:  2014-06-14       Impact factor: 17.079

View more
  4 in total

Review 1.  16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora.

Authors:  Tianhao Liu; Zhongshan Yang; Xiaomei Zhang; Niping Han; Jiali Yuan; Yu Cheng
Journal:  3 Biotech       Date:  2017-10-12       Impact factor: 2.406

2.  Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia.

Authors:  T Gosiewski; A H Ludwig-Galezowska; K Huminska; A Sroka-Oleksiak; P Radkowski; D Salamon; J Wojciechowicz; M Kus-Slowinska; M Bulanda; P P Wolkow
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-22       Impact factor: 3.267

3.  Bacterial microbiome in the nose of healthy cats and in cats with nasal disease.

Authors:  Elisabeth S Dorn; Barbara Tress; Jan S Suchodolski; Tariq Nisar; Prajesh Ravindran; Karin Weber; Katrin Hartmann; Bianka S Schulz
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 4.  The Hoops, Hopes, and Hypes of Human Microbiome Research.

Authors:  Elisabeth M Bik
Journal:  Yale J Biol Med       Date:  2016-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.